443 related articles for article (PubMed ID: 26031764)
21. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK; Talukder M; Williams G
J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
[TBL] [Abstract][Full Text] [Related]
22. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
23. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
[TBL] [Abstract][Full Text] [Related]
26. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
Melo DF; de Mattos Barreto T; Plata GT; Araujo LR; Tortelly VD
J Cosmet Dermatol; 2020 Jan; 19(1):75-77. PubMed ID: 31066492
[TBL] [Abstract][Full Text] [Related]
27. Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
Liu C; Zhao H; Zhang Y; Wu W
J Cosmet Dermatol; 2022 Sep; 21(9):4053-4059. PubMed ID: 35037386
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss.
Won YY; Lew BL; Sim WY
Dermatol Ther; 2018 Mar; 31(2):e12588. PubMed ID: 29464847
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
[No Abstract] [Full Text] [Related]
30. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
[TBL] [Abstract][Full Text] [Related]
31. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
32. Hair loss.
Patel JC
Indian J Med Sci; 2000 Mar; 54(3):106-9. PubMed ID: 11227614
[No Abstract] [Full Text] [Related]
33. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Gupta AK; Venkataraman M; Talukder M; Bamimore MA
JAMA Dermatol; 2022 Mar; 158(3):266-274. PubMed ID: 35107565
[TBL] [Abstract][Full Text] [Related]
34. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.
Faghihi G; Mozafarpoor S; Asilian A; Mokhtari F; Esfahani AA; Bafandeh B; Nouraei S; Nilforoushzadeh MA; Hosseini SM
Indian J Dermatol Venereol Leprol; 2018; 84(5):547-553. PubMed ID: 30027912
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
[TBL] [Abstract][Full Text] [Related]
37. [Drug treatment of alopecia].
Wolff H
Internist (Berl); 2015 Oct; 56(10):1196-208. PubMed ID: 26383761
[TBL] [Abstract][Full Text] [Related]
38. What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
40. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
Wu M; Yu Q; Li Q
Oncotarget; 2016 Dec; 7(50):82074-82084. PubMed ID: 27738338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
